The beneficial effect of insulin degludec on nocturnal hypoglycaemia and insulin dose in type 1 diabetic patients: a systematic review and meta-analysis of randomised trials. (Q35457098)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	The beneficial effect of insulin degludec on nocturnal hypoglycaemia and insulin dose in type 1 diabetic patients: a systematic review and meta-analysis of randomised trials.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25430705%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

0 references

1 reference

Europe PubMed Central

The beneficial effect of insulin degludec on nocturnal hypoglycaemia and insulin dose in type 1 diabetic patients: a systematic review and meta-analysis of randomised trials (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25430705%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference

based on heuristic

inferred from title

systematic review

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Dominik Golicki

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25430705%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

author name string

K Dżygało

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25430705%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

A Kowalska

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25430705%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

A Szypowska

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25430705%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

publication date

28 November 2014

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25430705%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Acta Diabetologica

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25430705%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

52

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25430705%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

231-238

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25430705%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25430705%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

https://scigraph.springernature.com/pub.10.1007/s00592-014-0604-0

0 references

Reduced risk of hypoglycemia with insulin degludec versus insulin glargine in patients with type 2 diabetes requiring high doses of basal insulin: a meta-analysis of 5 randomized begin trials

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0604-0

21 January 2018

Efficacy and safety of degludec insulin: a meta-analysis of randomised trials

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0604-0

21 January 2018

The impact of non-severe hypoglycemic events on work productivity and diabetes management.

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0604-0

21 January 2018

Hypoglycemia in children with type 1 diabetes: current issues and controversies

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0604-0

21 January 2018

Multivariate models of health-related utility and the fear of hypoglycaemia in people with diabetes.

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0604-0

21 January 2018

Insulin degludec: four times lower pharmacodynamic variability than insulin glargine under steady-state conditions in type 1 diabetes.

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0604-0

21 January 2018

Design of the novel protraction mechanism of insulin degludec, an ultra-long-acting basal insulin.

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0604-0

21 January 2018

Elderly patients with diabetes experience a lower rate of nocturnal hypoglycaemia with insulin degludec than with insulin glargine: a meta-analysis of phase IIIa trials

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0604-0

21 January 2018

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0604-0

21 January 2018

Insulin degludec in type 1 diabetes: a randomized controlled trial of a new-generation ultra-long-acting insulin compared with insulin glargine.

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0604-0

21 January 2018

Efficacy and safety of insulin degludec in a flexible dosing regimen vs insulin glargine in patients with type 1 diabetes (BEGIN: Flex T1): a 26-week randomized, treat-to-target trial with a 26-week extension

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0604-0

21 January 2018

Insulin degludec/insulin aspart administered once daily at any meal, with insulin aspart at other meals versus a standard basal-bolus regimen in patients with type 1 diabetes: a 26-week, phase 3, randomized, open-label, treat-to-target trial

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0604-0

21 January 2018

Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority tria

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0604-0

21 January 2018

Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes: "double diabetes" in the Diabetes Control and Complications Trial.

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0604-0

21 January 2018

Is glycaemia or insulin dose the stronger risk factor for coronary artery disease in type 1 diabetes?

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0604-0

21 January 2018

Current clinical status, glucose control, and complication rates of children and youth with type 1 diabetes in Rwanda

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0604-0

21 January 2018

Iatrogenic hyperinsulinemia in type 1 diabetes: its effect on atherogenic risk markers

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0604-0

21 January 2018

Characteristics of Type 1 diabetes of over 50 years duration (the Golden Years Cohort)

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0604-0

21 January 2018

Identifiers

10.1007/S00592-014-0604-0

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25430705%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25430705%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35457098&oldid=1948538833"